Table of Contents Chapter 1 Overview of Nuclear Medicine Radiopharmaceuticals 1.1 Definition of Nuclear Medicine Radiopharmaceuticals in This Report 1.2 Commercial Types of Nuclear Medicine Radiopharmaceuticals 1.2.1 Diagnostic 1.2.2 Brachytherapy 1.2.3 Other Therapeutic 1.3 Downstream Application of Nuclear Medicine Radiopharmaceuticals 1.3.1 Oncology 1.3.2 Thyroid 1.3.3 Cardiology 1.3.4 Others 1.4 Development History of Nuclear Medicine Radiopharmaceuticals 1.5 Market Status and Trend of Nuclear Medicine Radiopharmaceuticals 2013-2023 1.5.1 Europe Nuclear Medicine Radiopharmaceuticals Market Status and Trend 2013-2023 1.5.2 Regional Nuclear Medicine Radiopharmaceuticals Market Status and Trend 2013-2023 Chapter 2 Europe Market Status and Forecast by Regions 2.1 Market Status of Nuclear Medicine Radiopharmaceuticals in Europe 2013-2017 2.2 Consumption Market of Nuclear Medicine Radiopharmaceuticals in Europe by Regions 2.2.1 Consumption Volume of Nuclear Medicine Radiopharmaceuticals in Europe by Regions 2.2.2 Revenue of Nuclear Medicine Radiopharmaceuticals in Europe by Regions 2.3 Market Analysis of Nuclear Medicine Radiopharmaceuticals in Europe by Regions 2.3.1 Market Analysis of Nuclear Medicine Radiopharmaceuticals in Germany 2013-2017 2.3.2 Market Analysis of Nuclear Medicine Radiopharmaceuticals in United Kingdom 2013-2017 2.3.3 Market Analysis of Nuclear Medicine Radiopharmaceuticals in France 2013-2017 2.3.4 Market Analysis of Nuclear Medicine Radiopharmaceuticals in Italy 2013-2017 2.3.5 Market Analysis of Nuclear Medicine Radiopharmaceuticals in Spain 2013-2017 2.3.6 Market Analysis of Nuclear Medicine Radiopharmaceuticals in Benelux 2013-2017 2.3.7 Market Analysis of Nuclear Medicine Radiopharmaceuticals in Russia 2013-2017 2.4 Market Development Forecast of Nuclear Medicine Radiopharmaceuticals in Europe 2018-2023 2.4.1 Market Development Forecast of Nuclear Medicine Radiopharmaceuticals in Europe 2018-2023 2.4.2 Market Development Forecast of Nuclear Medicine Radiopharmaceuticals by Regions 2018-2023 Chapter 3 Europe Market Status and Forecast by Types 3.1 Whole Europe Market Status by Types 3.1.1 Consumption Volume of Nuclear Medicine Radiopharmaceuticals in Europe by Types 3.1.2 Revenue of Nuclear Medicine Radiopharmaceuticals in Europe by Types 3.2 Europe Market Status by Types in Major Countries 3.2.1 Market Status by Types in Germany 3.2.2 Market Status by Types in United Kingdom 3.2.3 Market Status by Types in France 3.2.4 Market Status by Types in Italy 3.2.5 Market Status by Types in Spain 3.2.6 Market Status by Types in Benelux 3.2.7 Market Status by Types in Russia 3.3 Market Forecast of Nuclear Medicine Radiopharmaceuticals in Europe by Types Chapter 4 Europe Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Nuclear Medicine Radiopharmaceuticals in Europe by Downstream Industry 4.2 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in Major Countries 4.2.1 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in Germany 4.2.2 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in United Kingdom 4.2.3 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in France 4.2.4 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in Italy 4.2.5 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in Spain 4.2.6 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in Benelux 4.2.7 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in Russia 4.3 Market Forecast of Nuclear Medicine Radiopharmaceuticals in Europe by Downstream Industry Chapter 5 Market Driving Factor Analysis of Nuclear Medicine Radiopharmaceuticals 5.1 Europe Economy Situation and Trend Overview 5.2 Nuclear Medicine Radiopharmaceuticals Downstream Industry Situation and Trend Overview Chapter 6 Nuclear Medicine Radiopharmaceuticals Market Competition Status by Major Players in Europe 6.1 Sales Volume of Nuclear Medicine Radiopharmaceuticals in Europe by Major Players 6.2 Revenue of Nuclear Medicine Radiopharmaceuticals in Europe by Major Players 6.3 Basic Information of Nuclear Medicine Radiopharmaceuticals by Major Players 6.3.1 Headquarters Location and Established Time of Nuclear Medicine Radiopharmaceuticals Major Players 6.3.2 Employees and Revenue Level of Nuclear Medicine Radiopharmaceuticals Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Nuclear Medicine Radiopharmaceuticals Major Manufacturers Introduction and Market Data 7.1 Mallinckrodt 7.1.1 Company profile 7.1.2 Representative Nuclear Medicine Radiopharmaceuticals Product 7.1.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Mallinckrodt 7.2 Isorad 7.2.1 Company profile 7.2.2 Representative Nuclear Medicine Radiopharmaceuticals Product 7.2.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Isorad 7.3 Cardinal Health 7.3.1 Company profile 7.3.2 Representative Nuclear Medicine Radiopharmaceuticals Product 7.3.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Cardinal Health 7.4 Jubilant 7.4.1 Company profile 7.4.2 Representative Nuclear Medicine Radiopharmaceuticals Product 7.4.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jubilant 7.5 Medi-Radiopharma 7.5.1 Company profile 7.5.2 Representative Nuclear Medicine Radiopharmaceuticals Product 7.5.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Medi-Radiopharma 7.6 Comecer 7.6.1 Company profile 7.6.2 Representative Nuclear Medicine Radiopharmaceuticals Product 7.6.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Comecer 7.7 Jaco 7.7.1 Company profile 7.7.2 Representative Nuclear Medicine Radiopharmaceuticals Product 7.7.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jaco 7.8 Ciaeriar 7.8.1 Company profile 7.8.2 Representative Nuclear Medicine Radiopharmaceuticals Product 7.8.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Ciaeriar 7.9 Advanced Molecular-imaging Solution 7.9.1 Company profile 7.9.2 Representative Nuclear Medicine Radiopharmaceuticals Product 7.9.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Advanced Molecular-imaging Solution Chapter 8 Upstream and Downstream Market Analysis of Nuclear Medicine Radiopharmaceuticals 8.1 Industry Chain of Nuclear Medicine Radiopharmaceuticals 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Nuclear Medicine Radiopharmaceuticals 9.1 Cost Structure Analysis of Nuclear Medicine Radiopharmaceuticals 9.2 Raw Materials Cost Analysis of Nuclear Medicine Radiopharmaceuticals 9.3 Labor Cost Analysis of Nuclear Medicine Radiopharmaceuticals 9.4 Manufacturing Expenses Analysis of Nuclear Medicine Radiopharmaceuticals Chapter 10 Marketing Status Analysis of Nuclear Medicine Radiopharmaceuticals 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Diagnostic Table Advantage and Disadvantage of Brachytherapy Table Advantage and Disadvantage of Other Therapeutic Table Consumption Volume of Nuclear Medicine Radiopharmaceuticals in Europe by Regions 2013-2017 Table Revenue of Nuclear Medicine Radiopharmaceuticals in Europe by Regions 2013-2017 Table Consumption Volume of Nuclear Medicine Radiopharmaceuticals in Europe by Regions 2018-2023 Table Revenue of Nuclear Medicine Radiopharmaceuticals in Europe by Regions 2018-2023 Table Consumption Volume of Nuclear Medicine Radiopharmaceuticals in Europe by Types 2013-2017 Table Revenue of Nuclear Medicine Radiopharmaceuticals in Europe by Types 2013-2017 Table Consumption Volume of Nuclear Medicine Radiopharmaceuticals by Types in Germany 2013-2017 Table Consumption Volume of Nuclear Medicine Radiopharmaceuticals by Types in United Kingdom 2013-2017 Table Consumption Volume of Nuclear Medicine Radiopharmaceuticals by Types in France 2013-2017 Table Consumption Volume of Nuclear Medicine Radiopharmaceuticals by Types in Italy 2013-2017 Table Consumption Volume of Nuclear Medicine Radiopharmaceuticals by Types in Spain 2013-2017 Table Consumption Volume of Nuclear Medicine Radiopharmaceuticals by Types in Benelux 2013-2017 Table Consumption Volume of Nuclear Medicine Radiopharmaceuticals by Types in Russia 2013-2017 Table Consumption Volume Forecast of Nuclear Medicine Radiopharmaceuticals in Europe by Types 2018-2023 Table Revenue Forecast of Nuclear Medicine Radiopharmaceuticals in Europe by Types 2018-2023 Table Demand Volume of Nuclear Medicine Radiopharmaceuticals in Europe by Downstream Industry 2013-2017 Table Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in Germany 2013-2017 Table Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in United Kingdom 2013-2017 Table Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in France 2013-2017 Table Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in Italy 2013-2017 Table Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in Spain 2013-2017 Table Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in Benelux 2013-2017 Table Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry in Russia 2013-2017 Table Demand Volume Forecast of Nuclear Medicine Radiopharmaceuticals in Europe by Downstream Industry 2018-2023 Table Sales Volume of Nuclear Medicine Radiopharmaceuticals in Europe by Major Players 2013-2017 Table Revenue of Nuclear Medicine Radiopharmaceuticals in Europe by Major Players 2013-2017 Table Headquarters Location and Established Time of Nuclear Medicine Radiopharmaceuticals Major Players Table Employees and Revenue Level of Nuclear Medicine Radiopharmaceuticals Major Players Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Mallinckrodt Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Mallinckrodt Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Mallinckrodt 2013-2017 Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Isorad Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Isorad Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Isorad 2013-2017 Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Cardinal Health Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Cardinal Health Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Cardinal Health 2013-2017 Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Jubilant Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Jubilant Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jubilant 2013-2017 Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Medi-Radiopharma Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Medi-Radiopharma Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Medi-Radiopharma 2013-2017 Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Comecer Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Comecer Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Comecer 2013-2017 Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Jaco Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Jaco Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jaco 2013-2017 Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Ciaeriar Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Ciaeriar Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Ciaeriar 2013-2017 Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Advanced Molecular-imaging Solution Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Advanced Molecular-imaging Solution Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Advanced Molecular-imaging Solution 2013-2017